At the news
? NEUTRALIMPACT 2/10 144 filed Nov 6, 2026 at 16:04 ET
Director B. Kristine Johnson (via her trust) filed a Form 144 notice to sell 2,452 shares of AtriCure common stock, valued at approximately $143,397. The shares were acquired through restricted stock vesting under a registered plan in 2021. The sale is small relative to the company's $3.3B market cap and represents a routine diversification move by a director.
- Reporting owner: B. Kristine Johnson Declaration Trust (Director)
- Shares to be sold: 2,452 shares of common stock
- Estimated value: $143,397.13
- Shares acquired on 05/20/2021 via restricted stock vesting under a registered plan
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access